Establishment and validation of a novel risk model for estimating time to first treatment in 120 patients with chronic myelomonocytic leukaemia

Florian Huemer; Lukas Weiss; Viktoria Faber; Daniel Neureiter; Alexander Egle; Klaus Geissler; Daniela Voskova; Armin Zebisch; Sonja Burgstaller; Angelika Pichler; Reinhard Stauder; Wolfgang Sperr; Alois Lang; Michael Pfeilstöcker; Sigrid Machherndl-Spandl; Margarete Stampfl; Richard Greil; Lisa Pleyer

doi:10.1007/s00508-018-1315-2

Establishment and validation of a novel risk model for estimating time to first treatment in 120 patients with chronic myelomonocytic leukaemia

Florian Huemer
, Lukas Weiss
, Viktoria Faber
, Daniel Neureiter
, Alexander Egle
, Klaus Geissler
, Daniela Voskova
, Armin Zebisch
, Sonja Burgstaller
, Angelika Pichler
, Reinhard Stauder
, Wolfgang Sperr
, Alois Lang
, Michael Pfeilstöcker
, Sigrid Machherndl-Spandl
, Margarete Stampfl
, Richard Greil
, Lisa Pleyer

Faculty of Medicine

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	115-125
Number of pages	11
Journal	Wiener klinische Wochenschrift
Volume	130
Issue number	3-4
DOIs	https://doi.org/10.1007/s00508-018-1315-2
Publication status	Published - Feb 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Fields of science

303 Health Sciences
304 Medical Biotechnology
305 Other Human Medicine, Health Sciences
301 Medical-Theoretical Sciences, Pharmacy
302 Clinical Medicine

JKU Focus areas

Medical Sciences (in general)
Health System Research
Clinical Research on Aging

Access to Document

10.1007/s00508-018-1315-2

Cite this

Huemer, F., Weiss, L., Faber, V., Neureiter, D., Egle, A., Geissler, K., Voskova, D., Zebisch, A., Burgstaller, S., Pichler, A., Stauder, R., Sperr, W., Lang, A., Pfeilstöcker, M., Machherndl-Spandl, S., Stampfl, M., Greil, R., & Pleyer, L. (2018). Establishment and validation of a novel risk model for estimating time to first treatment in 120 patients with chronic myelomonocytic leukaemia. Wiener klinische Wochenschrift, 130(3-4), 115-125. https://doi.org/10.1007/s00508-018-1315-2

@article{c8d6fbacf979458fbff096635d657167,

title = "Establishment and validation of a novel risk model for estimating time to first treatment in 120 patients with chronic myelomonocytic leukaemia",

author = "Florian Huemer and Lukas Weiss and Viktoria Faber and Daniel Neureiter and Alexander Egle and Klaus Geissler and Daniela Voskova and Armin Zebisch and Sonja Burgstaller and Angelika Pichler and Reinhard Stauder and Wolfgang Sperr and Alois Lang and Michael Pfeilst{\"o}cker and Sigrid Machherndl-Spandl and Margarete Stampfl and Richard Greil and Lisa Pleyer",

year = "2018",

month = feb,

doi = "10.1007/s00508-018-1315-2",

language = "English",

volume = "130",

pages = "115--125",

journal = "Wiener klinische Wochenschrift",

issn = "1613-7671",

publisher = "Springer",

number = "3-4",

}

Huemer, F, Weiss, L, Faber, V, Neureiter, D, Egle, A, Geissler, K, Voskova, D, Zebisch, A, Burgstaller, S, Pichler, A, Stauder, R, Sperr, W, Lang, A, Pfeilstöcker, M, Machherndl-Spandl, S, Stampfl, M, Greil, R & Pleyer, L 2018, 'Establishment and validation of a novel risk model for estimating time to first treatment in 120 patients with chronic myelomonocytic leukaemia', Wiener klinische Wochenschrift, vol. 130, no. 3-4, pp. 115-125. https://doi.org/10.1007/s00508-018-1315-2

TY - JOUR

T1 - Establishment and validation of a novel risk model for estimating time to first treatment in 120 patients with chronic myelomonocytic leukaemia

AU - Huemer, Florian

AU - Weiss, Lukas

AU - Faber, Viktoria

AU - Neureiter, Daniel

AU - Egle, Alexander

AU - Geissler, Klaus

AU - Voskova, Daniela

AU - Zebisch, Armin

AU - Burgstaller, Sonja

AU - Pichler, Angelika

AU - Stauder, Reinhard

AU - Sperr, Wolfgang

AU - Lang, Alois

AU - Pfeilstöcker, Michael

AU - Machherndl-Spandl, Sigrid

AU - Stampfl, Margarete

AU - Greil, Richard

AU - Pleyer, Lisa

PY - 2018/2

Y1 - 2018/2

UR - https://www.ncbi.nlm.nih.gov/pubmed/29383443

UR - https://www.scopus.com/pages/publications/85041198393

U2 - 10.1007/s00508-018-1315-2

DO - 10.1007/s00508-018-1315-2

M3 - Article

C2 - 29383443

SN - 1613-7671

VL - 130

SP - 115

EP - 125

JO - Wiener klinische Wochenschrift

JF - Wiener klinische Wochenschrift

IS - 3-4

ER -

Establishment and validation of a novel risk model for estimating time to first treatment in 120 patients with chronic myelomonocytic leukaemia

UN SDGs

Fields of science

JKU Focus areas

Access to Document

Other files and links

Cite this